For example, the application of programmed death 1 (PD-1) inhibitors in ESCA, advanced liver cancer, and locally advanced or metastatic GC has achieved good curative effects (Högner and Thuss-Patience, 2021; Joshi and Badgwell, 2021; Kim et al., 2021). Here, PDCD1 is linked to gastric cancer.